BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19372220)

  • 21. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
    Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
    Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
    Wang YS; Zhou J; Hong K; Cheng XS; Li YG
    Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.
    Wu X; Chang B; Blair NS; Sargent M; York AJ; Robbins J; Shull GE; Molkentin JD
    J Clin Invest; 2009 Apr; 119(4):976-85. PubMed ID: 19287093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.
    Facundo HT; Brainard RE; Watson LJ; Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2122-30. PubMed ID: 22408028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.
    Pedram A; Razandi M; Aitkenhead M; Levin ER
    J Biol Chem; 2005 Jul; 280(28):26339-48. PubMed ID: 15899894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
    Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.
    Hullmann JE; Grisanti LA; Makarewich CA; Gao E; Gold JI; Chuprun JK; Tilley DG; Houser SR; Koch WJ
    Circ Res; 2014 Dec; 115(12):976-85. PubMed ID: 25332207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy.
    Putinski C; Abdul-Ghani M; Stiles R; Brunette S; Dick SA; Fernando P; Megeney LA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):E4079-87. PubMed ID: 24101493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
    Choukroun G; Hajjar R; Kyriakis JM; Bonventre JV; Rosenzweig A; Force T
    J Clin Invest; 1998 Oct; 102(7):1311-20. PubMed ID: 9769323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
    Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
    Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
    Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
    Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
    J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
    Obasanjo-Blackshire K; Mesquita R; Jabr RI; Molkentin JD; Hart SL; Marber MS; Xia Y; Heads RJ
    Cardiovasc Res; 2006 Sep; 71(4):672-83. PubMed ID: 16828070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
    Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
    J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
    Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
    J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy.
    Kramann N; Hasenfuß G; Seidler T
    Cardiovasc Res; 2014 Apr; 102(1):88-96. PubMed ID: 24492844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.